Antimicrobial articles produced by additive manufacturing
An antibiotic-eluting article for implantation into a mammalian subject, produced by an additive manufacturing process wherein a polymeric material is concurrently deposited with a selected antibiotic. The additive manufacturing process may be a fused deposition modeling process, a selective laser sintering process, a selective heat sintering process, a digital light processing process, or a stereolithography process. The antibiotic-eluting article may be temporary or permanent orthopaedic skeletal component, an orthopaedic articulating joint replacement component, and/or an external hard-shell casing for an implantable device. One or more bone-growth-promoting compositions may be concurrently deposited with the polymeric material. The implantable device may be a cardiac pacemaker, a spinal cord stimulator, a neurostimulation system, an intrathecal drug pump for delivery of medicants into the spinal fluid, and infusion pump for delivery of chemotherapeutics and/or anti-spasmodics, an insulin pump, an osmotic pump, and a heparin pump.
1. An antibiotic-containing polymeric mono-filament consisting of:
a dry blend of: a polymer and at least one antibiotic;
wherein the amount of the at least one antibiotic is between about 0.1 weight percent and about 20.0 weight percent relative to the total weight of the antibiotic-containing polymeric mono-filament;
wherein the polymer is selected from the group consisting of: polylactic acid, polycaprolactone, polyamide, and polyethylene;
wherein the diameter of the antibiotic-containing polymeric mono-filament is in the range of about 0.89 millimeters to about 3.0 millimeters,
wherein the polymer and the at least one antibiotic are homogenously distributed throughout the antibiotic-containing polymeric mono-filament,
wherein the dry blend has been extruded through an extrusion die to produce the antibiotic-containing polymeric mono-filament, and
wherein the antibiotic-containing polymeric mono-filament is extrudable through a fused deposition modelling machine to produce an antibiotic-eluting article having the at least one antibiotic homogenously distributed throughout and elutable from the antibiotic-eluting article.
2. The antibiotic-containing polymeric mono-filament of claim 1 , wherein the antibiotic is selected from the group consisting of an aminoglycoside, an azole, a β-lactam antibiotic, a β-lactamase inhibitor, a cephalosporin, chloramphenicol, clindamycin, fusidic acid, a glycopeptide, a macrolide, metronidazole, mupirocin, a penicillin, a polyene, a quinolone, a rifamycin, a sulfonamide, tetracycline, trimethoprim, and combinations thereof.
3. The antibiotic-containing polymeric mono-filament of claim 1 , wherein the amount of the at least one antibiotic is between about 0.5 weight percent and about 10.0 weight percent relative to the total weight of the antibiotic-containing polymeric mono-filament.
4. The antibiotic-containing polymeric mono-filament of claim 1 , wherein the amount of the at least one antibiotic is between about 0.75 weight percent and about 5.0 weight percent relative to the total weight of the antibiotic-containing polymeric mono-filament.
5. An antibiotic-containing polymeric mono-filament consisting of:
a dry blend of: a polymer, at least one antibiotic, and a bone-growth-promoting composition;
wherein the amount of the at least one antibiotic is between about 0.1 weight percent and about 20.0 weight percent relative to the total weight of the antibiotic-containing polymeric mono-filament;
wherein the polymer is selected from the group consisting of: polylactic acid, polycaprolactone, polyamide, and polyethylene;
wherein the diameter of the antibiotic-containing polymeric mono-filament is in the range of about 0.89 millimeters to about 3.0 millimeters,
wherein the polymer and the at least one antibiotic are homogenously distributed throughout the antibiotic-containing polymeric mono-filament,
wherein the dry blend has been extruded through an extrusion die to produce the antibiotic-containing polymeric mono-filament, and
wherein the antibiotic-containing polymeric mono-filament is extrudable through a fused deposition modelling machine to produce an antibiotic-eluting article having the at least one antibiotic homogenously distributed throughout and elutable from the antibiotic-eluting article.
6. The antibiotic-containing polymeric mono-filament of claim 5 , wherein the bone-growth-promoting composition is selected from the group consisting of: hyaluronic acid, β-(tricalcium phosphate), SOST (sclerostin), an antagonist that modulates the Wnt signaling pathway, (3-((4(4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)-phenoxy-)-acetic-acid and its analogs, 7-[(4-butyl-benzyl)-methanesulfonyl-amino]heptanoic acid and its analogs, 7-{[2-(3,5-dichloro-phenoxyl)-ethyl]-methanesulfonyl-amino}-heptanoic acid and its analogs, and 3-benzothiepin derivatives.